Two different apoptotic pathways leading to activation of cell-specific programs have been hypothesized. 1 Cell types might therefore belong to two main prototypes and respond differently to apoptotic stimuli, eventually converging towards mitochondrially driven cascade. 2, 3 This can be seen in cells of different histotypes and is characterized by loss of mitochondrial membrane potential (MMP) and opening of the mitochondrial megapore. This leads to the release of apoptogenic factors (cytochrome c and apoptosis-inducing factor), and downstream execution phase cascade involving apoptosome formation and caspase 9 activation. Caspase 3 activation and consequent cleavage of several substrates (e.g. poly-ADPribose-polymerase) are the final events. 3, 4 Certain chemical, biological and physical agents have been described as affecting cell fate by directly acting on MMP. [5] [6] [7] Some of these 'mitochondriotropic' agents decrease MMP and apoptosis, while others hinder cell suicide. 8 Literature clearly suggests that activated human lymphocytes are highly sensitive to apoptotic triggers while resting T cells are 'refractory' to apoptotic stimulations such as monoclonal IgM anti-Fas antibodies (a-Fas). 9, 10 In fact, activation of isolated human lymphocytes by using (i) phytohemagglutinin (PHA): (ii) anti-CD3 monoclonal antibody (a-CD3) and (iii) human immunodeficiency virus envelope protein gp120 11 in combined treatments with interleukin-2 (IL2) led to a significantly increased susceptibility to a-Fas-induced apoptosis ( Figure 1 ). In the light of this activation-increased apoptotic proneness and the key role played by mitochondria in apoptotic cell death, a specific analysis of MMP was conducted. Three different probes were used: 3,3 0 -dihexyloxacarbocyanine iodide (DiOC6), 2 tetramethylrhodamine ester (TMRM) 12, 13 and 5-5
14 These probes are commonly used in flow and static cytometry studies and yield overlapping results; they have therefore been considered interchangable. Experiments were performed in IL2-activated cells with or without the costimulatory molecules indicated above (PHA, a-CD3, gp120). Shepherding light through the MMP features of variously activated T cells, a striking behavior was detected. Compared to resting cells, median values of the fluorescence intensity histogram were significantly increased (corresponding to an increase of mitochondrial membrane polarization, Table 1B ). This increase was positively correlated (Po0.01) with increased expression of different T-cell activation markers on the cell surface, for example, CD69, HLA-DR (Table 1A) Figure 2b ). This increase was actually because of a hyperpolarization state of mitochondria and not because of increased dye uptake due to mitochondrial mass growth occurring during activation. In fact, cytofluorimetric analysis using the specific probe nonylacridine orange (5 mM NAO, Molecular Probes) clearly indicated that mitochondrial mass was substantially unchanged by T-cell activation (median values of the fluorescence intensity histograms were 49.172 and 48.672.5 for resting and activated lymphocytes, respectively). After 48 h a-Fas treatment produced the MMP loss typical of apoptotic cell death effector phase 15 in activated cells only. This is illustrated in Figure 2e 
Agents capable of specifically influencing MMP homeostasis were therefore examined in terms of their ability to modulate apoptotic proneness in resting and activated T cells. Low doses were used of the protonophore uncoupler carbonyl cyanide fluorophenyl-hydrazone (FCCP), 16 known to hinder mitochondria hyperpolarization, and the antibiotic drug oligomycin (OLM), known to influence mitochondrial homeostasis by increasing MMP. 17 FCCP was ineffective in resting T cells, leaving the MMP largely unchanged (Figure 3a) and T cells remained refractory to a-Fas stimulation (Figure 3b ). Conversely, FCCP was able to hinder the IL-2-induced MMP increase ( Figure 3c , compare with Figure 2c ) and, consequently, to protect IL2-activated T lymphocytes from a-Fasinduced late events, that is, MMP depolarization (Figure 3d , III quadrant). Apoptosis was accordingly significantly decreased (À8175%). OLM had the opposite effect. In resting T cells, OLM induced per se a significant mitochondrial membrane hyperpolarization state (Figure 3e ). This was enough to hijack resting T cells towards a more apoptotic-prone phenotype. In fact, a significant increase in the percentage of apoptotic cells (+160712%) was detected compared to OLM-free resting T cells. In IL-2-activated T cells, where cytokine activation had already increased MMP (Figure 3g ), OLM induced a significant further increase (+65%) of cells displaying typical signs of a-Fas-mediated apoptosis with respect to OLM-free cells ( Figure 3H, III quadrant) .
Overall, these results clearly indicated that (i) the 'stabilizing' effect of FCCP on MMP decreased apoptotic proneness, while (ii) the presence of a 'mitochondriotropic' drug such as OLM, inducing mitochondrial hyperpolarization (increasing MMP), led to increased apoptotic sensitivity. Accordingly, we also observed that freshly isolated T cells from naive 
